INTERLEUKIN-1

被引:19
|
作者
DOWER, SK [1 ]
BIRD, TA [1 ]
SIMS, JE [1 ]
机构
[1] IMMUNEX RES & DEV CORP, DEPT MOLEC BIOL, SEATTLE, WA 98101 USA
来源
ADVANCES IN NEUROIMMUNOLOGY | 1992年 / 2卷 / 01期
关键词
D O I
10.1016/S0960-5428(06)80002-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
inflammatory processes are controlled by a complex network of interacting regulatory elements including, but not limited to, antigen-specific components of the immune system, cytokines and growth factors, cognate cellular interactions, cell matrix interactions and non-peptide mediators such as prostaglandins. Among these elements, considerable interest has focussed on interleukin 1 (IL-1), to a large extent because this polypeptide mediator was identified early on as a highly pleiotropic molecule that can, by itself, elicit many of the responses associated with acute and chronic inflammatory disease. The advent of molecular biology and modern protein microchemistry has led to a rapid expansion of our understanding of the molecular basis of IL-1 action. At present three species of IL-1 and two types of cell surface IL-1 receptors have been identified and cloned. One of the three species of IL-1 appears to be a pure receptor antagonist. In this chapter the current status of our understanding of the molecular basis of IL-1 action is reviewed.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [31] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    CLARK, BD
    MANCILLA, J
    DINARELLO, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (22) : 14147 - 14150
  • [32] Plasma interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist levels in pre-eclampsia
    Kimya, Y
    Akdis, C
    Cengiz, C
    Ozan, H
    Tatlikazan, S
    Uncu, G
    Sengul, F
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1997, 73 (01): : 17 - 21
  • [33] Balance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in the Development of Atherosclerosis - A Polymorphism in the Interleukin-1 Receptor Antagonist -
    Iida, Shinichiro
    Komiyama, Nobuyuki
    [J]. CIRCULATION JOURNAL, 2009, 73 (08) : 1401 - 1402
  • [34] NUCLEAR INTERNALIZATION AND DNA-BINDING ACTIVITIES OF INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR AND INTERLEUKIN-1 RECEPTOR COMPLEXES
    WEITZMANN, MN
    SAVAGE, N
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 187 (02) : 1166 - 1171
  • [35] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    MANCILLA, J
    CLARK, BD
    DINARELLO, CA
    [J]. CLINICAL RESEARCH, 1991, 39 (02): : A462 - A462
  • [36] The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system
    Loppnow, H
    Werdan, K
    Reuter, G
    Flad, HD
    [J]. EUROPEAN CYTOKINE NETWORK, 1998, 9 (04) : 675 - 680
  • [37] Interleukin-1 receptor accessory protein is required for interleukin-1 signalling
    Martin, M
    Wesche, H
    Resch, K
    Lang, D
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 302 - 302
  • [38] INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY
    AREND, WP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05): : 1445 - 1451
  • [39] INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR
    HANNUM, CH
    WILCOX, CJ
    AREND, WP
    JOSLIN, FG
    DRIPPS, DJ
    HEIMDAL, PL
    ARMES, LG
    SOMMER, A
    EISENBERG, SP
    THOMPSON, RC
    [J]. NATURE, 1990, 343 (6256) : 336 - 340
  • [40] Release of Interleukin-1α or Interleukin-1β Depends on Mechanism of Cell Death
    England, Hazel
    Summersgill, Holly R.
    Edye, Michelle E.
    Rothwell, Nancy J.
    Brough, David
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (23) : 15942 - 15950